164. Oculocutaneous albinism Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 15 / Drugs : 54 - (DrugBank : 34) / Drug target genes : 35 - Drug target pathways : 141
| Other names | - | ||
|---|---|---|---|
| Disease group | Eye diseases | ||
|
Domestic patients
Med expenses recipients (FY2023) |
34 patients Age distribution
 💬 |
||
| Related info (in Japanese) | - | ||
| Clinical research form [April 1, 2025 ~] (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 14-1-1. oculocutaneous albinism; OCA | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 164-1. | Hermansky-Pudlak syndrome; | ||
| 164-2. | Chediak-Higashi syndrome;Chédiak-Higashi syndrome; | 10-4-31. Chédiak-Higashi syndrome; CHS | |
| 164-3. | Griscelli syndrome; | ||
| 164-4. | Non-syndromic oculocutaneous albinism; | 14-1-1. oculocutaneous albinism; OCA | |